Bioventus Announces Its IPO

Update 2/11/21: The company announced the pricing of its initial public offering of 8,000,000 shares of Class A common stock at a public offering price of $13.00 per share.

Bioventus Inc., has commenced the initial public offering of its Class A common stock. It is offering 7,350,000 shares.
 
The initial public offering price is expected to be between $16.00 and $18.00 per share. Bioventus expects to grant the underwriters a 30-day option to purchase up to an additional 1,102,500 shares of its common stock at the initial public offering price to cover over-allotments. The shares are expected to trade on the Nasdaq Global Select Market under the ticker symbol “BVS.”
 
Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC are serving as joint lead book-running managers and as representatives of the underwriters for the proposed offering. Canaccord Genuity LLC is acting as lead manager for the offering.